论文部分内容阅读
本研究旨在对血清肌红蛋白（Mb）／碳酸酐酶Ⅲ（CAⅢ）比值作为早期诊断急性心肌梗塞（AMT）的生化指标进行评价。对象为267例有AMI特征性症状并于3个月内连续收住院的患者。其中37例诊断为AMI（只包括胸痛开始的时间确定无疑且本次胸痛发作距入院时间＜24h的患者），余230例为
The aim of this study was to evaluate the ratio of serum MB / CAIII to the early diagnosis of acute myocardial infarction (AMT). The subjects were 267 patients with characteristic symptoms of AMI who were admitted to hospital consecutively within 3 months. Among them, 37 cases were diagnosed as AMI (including only the time when the onset of chest pain was confirmed and the duration of the onset of chest pain was less than 24 hours), and the remaining 230 cases were